MULTICENTER, RANDOMIZED, DOUBLE-BLIND, COMPARATIVE WITH THE REFERENCE PRODUCT CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE THERAPY WITH THE COMBINATION OF BENZOYL PEROXIDE-ERYTHROMYCIN/VERISFIELD, GEL, (5+3)% W/W FOR THE TOPICAL TREATMENT OF ACNE VULGARIS

Registry ID

EUCTR2009-016240-40

Source registry

EUCTR

Status

Completed

Phase

PHASE1

Sponsor

VERISFIELD (UK) LTD, GREEK BRANCH

Start date

2010-04-14

Last update

2026-08-16

Conditions

• ACNE VULGARIS

Summary

THE MAIN OBJECTIVE OF THE TRIAL IS TO COMPARE THE EFFICACY OF THE TEST TOPICAL FORMULATION BENZOYL PEROXIDE-ERYTHROMYCIN/VERISFIELD, GEL, (5+3)% TO THE REFERENCE BENZADERMINE/LABORATOIRES PHARMACETIQUES TRENKER, GEL, (5+3)% AND TO EVALUATE THE THERAPEUTIC EQUIVALENCE BETWEEN THE TWO PRODUCTS IN PATIENTS WITH A CLINICAL DIAGNOSIS OF MILD TO MODERATE ACNE VULGARIS

Locations

• , , Greece

View on source registry